Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-2532

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70518-2532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Venlafaxine Hydrochloride extended-release capsules, 37.5 mg strength. The label indicates a quantity of 30 capsules. It shows NDC 70518-2532-00 and states the medication is repackaged by RemedyRepack Inc. The label also includes storage instructions and manufacturer information for Aurobindo, India.*

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A chart displaying pharmacokinetic (PK) fold changes and 90% confidence interval recommendations for venlafaxine when coadministered with various interacting drugs. The horizontal axis represents change relative to the reference value, and the chart includes recommendations such as dose adjustment notes and cautions for each interacting drug.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A pharmacokinetic chart illustrating the fold change in Cmax and AUC values, with 90% confidence intervals, for various interacting drugs with Venlafaxine Hydrochloride. The chart lists interacting drugs, analytes, and provides recommendations on dose adjustment or cautions based on clinical significance or PK changes.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A chart depicting pharmacokinetic changes of Venlafaxine in various special populations, including hepatic and renal impairment, CYP2D6 polymorphism, age over 60 years, and gender. The graph shows fold change with confidence intervals for Cmax and AUC values relative to reference, alongside dosing recommendations such as dose reductions or no adjustment needed.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride depicted as a two-dimensional molecular diagram showing the arrangement of its atoms and functional groups including a methoxyphenyl group, a cyclohexanol ring, and a dimethylaminoethyl side chain with hydrochloride indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.